Innate Pharma S.A. (NASDAQ:IPHA) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lion Point Didric Cederholm | 81,151 | $103,873 | 0.62% | |
| 2. | Millennium Management Israel Englander | 10,064 | $12,882 | -51% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 43,524 | $55,711 | 0% | |
| 2. | 43,365 | $55,507 | 0% | |
| 3. | 4,734 | $6,057 | 0% | |
| 4. | 861 | $1,102 | 0% | |
| 5. | 240 | $307 | 0% |